Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Opgen Inc (NQ: OPGN )

1.360 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,393
Open 1.360
Bid (Size) 1.160 (22)
Ask (Size) 1.260 (5)
Prev. Close 1.360
Today's Range 1.360 - 1.360
52wk Range 0.9301 - 17.56
Shares Outstanding 46,557,750
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From OpGen, Inc.
Via Globe NewsWire
Earnings Outlook For OpGen
 
Via Benzinga

Performance

YTD
-59.72%
-59.72%
1 Month
+33.33%
+33.33%
3 Month
-46.46%
-46.46%
6 Month
-82.11%
-82.11%
1 Year
-92.00%
-92.00%

More News

Read More
OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2022 on March 29th at 4:30 p.m. Eastern Time
From OpGen, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
OpGen Subsidiary Ares Genetics Announces its Move to New Vienna Location and Provides Update on Business Growth
From OpGen, Inc.
Via Globe NewsWire
OpGen Announces Exercise of All Prefunded Warrants
From OpGen, Inc.
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
OpGen subsidiary Ares Genetics announces granting of key patent in China
From OpGen, Inc.
Via Globe NewsWire
OpGen Provides Preliminary Unaudited Revenue for FY 2022 and Business Update
From OpGen, Inc.
Via Globe NewsWire
OpGen Subsidiary Curetis Meets Several Key Milestones in FIND Collaboration Project
From OpGen, Inc.
Via Globe NewsWire
OpGen Announces Closing of $7.5 Million Public Offering
From OpGen, Inc.
Via Globe NewsWire
OpGen Announces Pricing of $7.5 Million Public Offering
From OpGen, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
OpGen Announced 1-for-20 Reverse Stock Split
From OpGen, Inc.
Via Globe NewsWire
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket
Via Benzinga
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.